Dosimetry by Means of Measurement of Hemoglobin Alkylation and Risk Estimation Based on the Rad-Equivalent Approach

  • S. Osterman-Golkar


To assist the regulatory agencies in protecting the public health it is not sufficient to identify genetic risk factors. As a basis for measures, such as setting of TLV, data have to be provided that make possible a prediction of the relation between the level of exposure and extent of the damage to human health. Despite extensive biological experimentation there is very little data which can be directly used in quantitative risk assessment of genotoxic compounds. The possibilities of estimating risk to man from experimental data are limited, especially, by lack of knowledge of qualitative and quantitative differences between experimental organisms and man in metabolism of foreign compounds and in efficiencies of repair functions. A further drawback of tests for genotoxic activity of conventional scope is a low resolving power. If for some reason, such as a high toxicity or low solubility, a compound cannot be investigated at doses much higher than the one that occurs in human environments, an unacceptable risk may well be hidden in a negative result (Ehrenberg, 1974, 1977; Ehrenberg and OstermanGolkar, 1980).


Ethylene Oxide Vinyl Chloride Benzyl Chloride Ethyl Methanesulfonate Quantitative Risk Assessment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aaron, C. S., 1976, Molecular dosimetry of chemical mutagens. Selection of appropriate target molecules for determining molecular dose to the germ line, Mutat. Res., 38: 303.Google Scholar
  2. Andersen, M. E., Gargas, M. L., Jones, R. A., and Jenkins, L. J., 1980, Determination of the kinetic constants for metabolism of inhaled toxicants in vivo using gas uptake measurements, Toxicol. Appl. Pharmacol., 54: 100.Google Scholar
  3. Borgâ, O., Hamberger, B. Malmfors, T., and Sjögvist, F., 1970, The role of plasma protein binding in the inhibitory effect of nortriptylineon the neuronal uptake of norepinephrine, Clin. Pharmacol.Ther., 11: 581.Google Scholar
  4. Bridges, B. A., 1973, Some general principles of mutagenicity screening and a possible framework for testing procedures, Environ. Health Persp., 6: 221.Google Scholar
  5. Calleman, C. J., 1981, Monitoring and risk assessment by means of alkyl groups in hemoglobin in persons occupationally exposed to mutagens and carcinogens, Hemisphere, in press.Google Scholar
  6. Calleman, C. J., Ehrenberg, L., Jansson, B., Osterman-Golkar, S., Segerbäck, D., Svensson, K., and Wachtmeister, C. A., 1978, Monitoring and risk assessment by means of alkyl groups in hemoglobin in persons occupationally exposed to ethylene oxide, J. Environ. Pathol. Toxicol., 2: 427.Google Scholar
  7. Chemical Industry Institute of Toxicology (CIIT), 1980, A twenty-four month inhalation toxicology study in Fisher-344 rats exposed to atmospheric ethylene gas - final report. Docket No. 12000, October 15 (1980).Google Scholar
  8. Committee 17, appointed by the Council of Environmental Mutagen Society, 1975, Environmental mutagenic hazards, Science, 187: 503Google Scholar
  9. Ehrenberg, L., 1974, Genetic toxicity of environmental chemicals, Acta Biol. Yugoslay., Ser. B., Genetika, 6: 367.Google Scholar
  10. Ehrenberg, L., 1977, Aspects of statistical inference in testing for genetic toxicity, in: B. Kilbey, et al., eds., “Handbook of Mutagenicity Test Procedures,” Elsevier/North Holland, Amsterdam.Google Scholar
  11. Ehrenberg, L., 1979; Risk assessment of ethylene oxide and other compounds, in: V. K. McElheny and S. Abrahamson, eds., Banbury Report 1, “Assessing Chemical Mutagens: The Risk to Humans,” Cold Spring Harbor Laboratory.Google Scholar
  12. Ehrenberg, L., 1980, Purposes and methods of comparing effects of radiation and chemicals, in: “Radiobiological Equivalents of Chemical Pollutants,” IAEA, Vienna.Google Scholar
  13. Ehrenberg, L., Hiesche, K. D., Osterman-Golkar, S., and Wennberg, I., 1974, Evaluation of genetic risks of alkylating agents: Tissue doses in the mouse from air contaminated with ethylene oxide, Mutat. Res., 24: 83.Google Scholar
  14. Ehrenberg, L., Moustacchi, E., and Osterman-Golkar, S., 1981, Dosimetry of genotoxic agents and dose-response relationships of their effects, Working paper for ICPEMC.Google Scholar
  15. Ehrenberg, L., and Osterman-Golkar, S., 1977, Reaction kinetics of chemical pollutants as a basis of risk estimates in terms of rad-equivalence, in: R. Chanet, ed., “Radiological Protection,” First Eur. Symp. on Rad-Equivalence, Commission of the European Communities, Luxembourg.Google Scholar
  16. Ehrenberg, L., and Osterman-Golkar, S., 1980, Alkylation of macromolecules for detecting mutagenic agents, Teratogenesis Carcinogenesis Mutagenesis, 1: 105.CrossRefGoogle Scholar
  17. Ehrenberg, L., Osterman-Golkar, S., Segerbäck, D., Svensson, K., and Calleman, C. J., 1977, Evaluation of genetic risks of alkylating agents, III. Alkylation of hemoglobin after metabolic conversion of ethene to ethene oxide in vivo Mutat. Res., 45: 185.Google Scholar
  18. Farmer, P. B., Bailey, E., Lamb, J. H., and Connors, T. A., 1980, Approach to the quantitation of alkylated amino acids in hemoglobin by gas chromatography mass spectrometry, Biomed. Mass. Spectrom., 7: 41.Google Scholar
  19. Fishbein, G. W., ed., Dec. 8, 1980, “Occupational Health & Safety Letter.”Google Scholar
  20. Frei, J. W., Swenson, D. H., Warren, W., and Lawley, P. D., 1978, Alkylation of deoxyribonucleic acid in vivo in various organs of C57B1 mice by the carcinogens N-methyl-N-nitrosourea, Nethyl-N-nitrosourea and ethyl methanesulfonate in relation to induction of thymic lymphoma, Biochem. J., 174: 1031.Google Scholar
  21. Heddle, J. A., and Anthanasiou, K., 1975, Mutation rate, genome size and their relation to the rec concept, Nature, 258: 359.PubMedCrossRefGoogle Scholar
  22. Hogstedt, C., Malmgvist, N., and Wadman, B., 1979a, Leukemia in ethylene oxide exposed personnel, JAMA, 241: 1132.PubMedCrossRefGoogle Scholar
  23. Hogstedt, C., Rohlén, O., Berndtsson, B. S., Axelsson, O., and Ehrenberg, L., 1979b, A cohort study of mortality and cancer incidence in ethylene oxide production workers, Brit. J. Ind. Med., 36: 276.Google Scholar
  24. Hussain, S., 1981, Doctoral Thesis, Stockholm (in preparation). Joyner, R. E., 1964, Chronic toxicity of ethylene oxide, Arch. Environ. Health, 8: 700.Google Scholar
  25. Latarjet, R., 1977, Quantitative mutagenesis by chemicals and by radiations: Prerequisites for the establishment of rad-equivalences, in: R. Chanet, ed., “Radiological Protection,” First Eur. Symp. on Rad-Equivalence, Commission of the European Communities, Luxembourg.Google Scholar
  26. Lee, W. R., 1976, Molecular dosimetry of chemical mutagens. Determination of molecular dose to the germ line, Mutat. Res., 38: 311.Google Scholar
  27. Murthy et al., 1981 (Manuscipt in preparation).Google Scholar
  28. Neumann, H. G., Metzler, M., and Töpner, W., 1977, Metabolic activation of diethylstilbestrol and amino-stilbene-derivates, Arch. Toxicol., 39: 21.Google Scholar
  29. Nguyen, L., Osterman-Golkar, S., Ward, J. B., Jr., and Legator, M. S., 1980, Detection of alkylating agents by the analysis of amino acid residues in hemoglobin and urine. II. Dosimetry in the rat of methyl methanesulfonate by amino acid analysis of N-methylhistidine in hemoglobin, manuscript.Google Scholar
  30. Osterman-Golkar, S., 1975, Studies on the reaction kinetics of biologically active electrophilic reagents as a basis for risk estimates, Thesis, Stockholm University, Sweden.Google Scholar
  31. Osterman-Golkar, S., and Ehrenberg, L., 1981, Covalent binding of reactive intermediates to hemoglobin as an approach for determining the metabolic activation of chemicals–Ethylene, Symposium on the “Metabolism and Pharmacokinetics of Environmental Chemicals in Man,” Sarasota, Florida, June 7–12, 1981.Google Scholar
  32. Osterman-Golkar, S., Ehrenberg, L., Segerbäck, D., and Hällström, I., 1976, Evaluation of genetic risks of alkylation agents. II. Hemoglobin as a dose monitor, Mutat. Res., 34: 1.Google Scholar
  33. Osterman-Golkar, S., Hultmark, D., Segerbäck, D., Calleman, C. J., Göthe, R., Ehrenberg, L., and Wachtmeister, C. A., 1977, Alkylation of DNA and proteins in mice exposed to vinyl chloride, Biochem. Biophys. Res. Commun., 76: 259.Google Scholar
  34. Pereira, M. A., and Chang, L., 1980, Binding of chemical carcinogens and mutagens to rat hemoglobin, Chem.-Biol. Interactions, 33: 301.Google Scholar
  35. Segerbäck, D., Calleman, C. J., Ehrenberg, L. Löfroth, G., and Osterman-Golkar, S., 1978, Evaluation of genetic risks of alkylating agents. IV. Quantitative determination of alkylated amino acids in hemoglobin as a measure of the dose after treatment of mice with methyl methanesulfonate, Mutat. Res., 49: 71.Google Scholar
  36. Segerbäck, D., 1981a, Estimation of genetic risks of alkylating agents. V. Methylation of DNA in the mouse by DDVP (2,2-dichlorovinyl dimethyl phosphate), Hereditas, 94: 73.PubMedCrossRefGoogle Scholar
  37. Segerbäck, D., 1981b, Alkylation of DNA and hemoglobin in hemoglobin in the mouse after exposure to ethylene, manuscripts.Google Scholar
  38. UNSCEAR, 1977, “A report of the United Nations Scientific Committee on the Effects of Atomic Radiation, General Assembly with Annexes,” Vol. II (A 8725), 27th Session, Suppl. No. 25, United Nations, New York.Google Scholar
  39. Walles, S., 1981, Reaction of benzyl chloride with hemaglobin and Dna in various organs of mice, Toxicol. Letters (in press).Google Scholar

Copyright information

© Springer Science+Business Media New York 1983

Authors and Affiliations

  • S. Osterman-Golkar
    • 1
  1. 1.Radiology Department Wallenberg LaboratoryUniversity of StockholmStockholmSweden

Personalised recommendations